Sanofi (SNYNF) Operating Leases (2019 - 2026)
Sanofi (SNYNF) posted Operating Leases of $1.9 billion for Q2 2026, up 14.15% sequentially from $1.7 billion in Q4 2025, and up 12.99% YoY from $1.7 billion in Q2 2025.
Sanofi (SNYNF) Operating Leases (2019 - 2026) Analysis & Trends
Sanofi has reported Operating Leases for 8 years, with the latest figure at $1.9 billion in Q2 2026.
- Quarterly Operating Leases rose 12.99% year-over-year to $1.9 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.9 billion (up 12.99% YoY) and the FY2025 annual result came in at $1.7 billion, down 16.16% from the prior year.
- Operating Leases climbed to $1.9 billion in Q2 2026 per SNYNF's latest filing, from $1.7 billion in the prior quarter.
- Over five years, Operating Leases peaked at $2.2 billion in Q4 2022 and troughed at $1.7 billion in Q4 2025.
- A 5-year average of $2.0 billion and a median of $2.0 billion in 2023 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2022 and 2025: Operating Leases jumped 42.75% in 2022, then declined 16.16% in 2025.
- Over 5 years, Operating Leases stood at $2.2 billion in 2022, then dropped by 1.84% to $2.2 billion in 2023, then decreased by 6.75% to $2.0 billion in 2024, then slipped by 16.16% to $1.7 billion in 2025, then climbed by 14.15% to $1.9 billion in 2026.
- According to Business Quant data, Operating Leases over the past three periods registered $1.9 billion, $1.7 billion, and $1.7 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.95 Bn |
| Dec 31, 2025 | 1.71 Bn |
| Jun 30, 2025 | 1.73 Bn |
| Dec 31, 2024 | 2.04 Bn |
| Jun 30, 2024 | 1.87 Bn |
| Dec 31, 2023 | 2.18 Bn |
| Jun 30, 2023 | 2.00 Bn |
| Dec 31, 2022 | 2.23 Bn |
| Jun 30, 2022 | 2.14 Bn |
| Dec 31, 2021 | 2.41 Bn |
| Jun 30, 2021 | 1.50 Bn |
| Dec 31, 2020 | 2.51 Bn |
| Jun 30, 2020 | 1.04 Bn |
| Dec 31, 2019 | 1.29 Bn |
| Jun 30, 2019 | 1.08 Bn |